A-1210477 is an binding inhibitor for MCL-1's ability to bind to BIM. Provided as 5mg of dry powder.
A-1210477 is a small molecule MCL-1 inhibitor with sufficient potency to disrupt the tight-binding MCL-1-BIM complex in living cells, achieving the hallmarks of intrinsic apoptosis, and demonstrating clear-on-target cancer cell killing capability either as a single agent or in combination with ABT-263 (Navitoclax). Provided as 5mg of dry powder.
| Marque | DiscoverX |
|---|---|
| Réf. B-LABO | BL-RE-170185 |
| Réf. fabricant | 17362619 |
| Quantité | 5 mg |
